In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


DynaGen files patent for breast biopsy technology:

This article was originally published in Clinica

Executive Summary

DynaGen has filed a patent application in the US for the methods and apparatus for sensing and imaging body and instruments during a surgical procedure. The company is stressing the performance of the product, the BioLocator system, in breast biopsy, which will be the initial focus of the company. Some eight million women in the US have a diagnostic evaluation for breast cancer each year; 750,000 will require a biopsy. DynaGen licensed the technology from BioLoc in December 1996 and has worldwide, exclusive rights.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts